Chairs: Roberta Rudà (Italy), Filip De Vos (Netherlands), Peter Hau (Germany)
Note that the programme is subject to change and will be continuously updated.
All times below refer to Central European Time (CET).
Saturday, November 4, 2023
10:00 - 10:45
M5.01 Molecular pathology of ependymomas and medulloblastomas
Felix Sahm, Germany
11:00 - 11:45
M5.02 Surgical therapy in ependymomas and medulloblastomas
Luca Regli, Switzerland
12:00 - 12:45
M5.03 Multimodal therapies for ependymomas and medulloblastomas
Peter Hau, Germany
12:45 - 13:45
Lunch Break
13:45 - 14:30
M5.04 Neuroimaging of rare brain tumors
tbc
14:45 - 15:30
M5.05 When and how radiotherapy has indication?
Frederic Dhermain, France
Sunday, November 5, 2023
10:00 - 10:45
M5.06 Molecular pathology of rare circumscribed gliomas and glioneuronal tumors
tbc
11:00 - 11:45
M5.07 Surgical therapy for rare circumscribed gliomas and glioneuronal tumors: oncological and epileptological value
Johan Pallud, France
12:00 - 12:45
M5.08 Multimodal therapies for rare circumscribed gliomas and glioneuronal tumors: case discussion
Roberta Rudà, Italy
12:45 - 13:45
Lunch Break
13:45 - 14:30
M5.09 Pineal and very rare tumors
Evangelia Razis, Greece
14:45 - 15:30
M5.10 New trial design and concepts for rare tumor
Mark Gilbert, United States
15:30 - 16:30
Test
CME credits
The European Association of Neuro-Oncology (EANO) will be seeking accreditation from the European Accreditation Council of Continuing Medical Education.